Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
about
The CD44+/CD24- phenotype is enriched in basal-like breast tumorsTumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation.Lung cancer-initiating cells: a novel target for cancer therapyCharacteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breastGains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer.Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases.Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan.Expression of hormone receptors in low-grade adenosquamous carcinoma of the breast: A case report.Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis.Prognostic value of CD44v6 expression in breast cancer: a meta-analysis
P2860
Q21092906-BD630136-0A4B-45CF-80AC-230B87C3D07AQ24801520-032E5597-501C-4630-9825-CA5C7C28F4F7Q26824222-C2389301-B6ED-4921-B198-60C6FC713FE7Q34124530-33531883-EE04-4F1A-8652-F382D007B46BQ34711966-512A8CF4-14FE-4BC2-A9E8-176309587EDAQ34936741-CB09D5A1-AA81-44E4-97DD-F65C295BB386Q35588805-D4A04725-5820-4A55-8978-CC99F5DDC83DQ35907460-3A8D0CA8-6C6C-474E-AC41-18F1C04F17D9Q36892916-0190C9BF-5917-4A7C-92D2-7A89395F8254Q36924387-B61CC0CE-EA51-4231-82F4-05AC663BF11AQ37242357-8A099A5C-2E4C-4E2F-8298-24FF5EE051DFQ40627879-1CBAD68D-9435-4102-AA15-F933A817B0E0Q41198035-B70112DC-F306-4DB2-9AC3-A45EA08EABB4Q42464623-757C515A-FC4C-4EEA-BDFD-88A11B9AF7DDQ42467556-50955592-C783-4FDD-BD29-4B14A75E0481Q42502215-9FA82C4E-B230-4818-A2D8-72844F489854Q46716321-C22E5D8C-D95E-4C8B-96E6-3A4F86742394Q47100181-A3086464-5513-497F-A4A5-7011D2231275Q50281677-F1443C26-9A51-466D-8A48-577EFB59B0CFQ58764989-7C01A571-3F3E-436E-A642-3FA15DB0B753
P2860
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
@en
type
label
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
@en
prefLabel
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
@en
P2093
P2860
P1433
P1476
Gains and losses of CD44 expression during breast carcinogenesis and tumour progression.
@en
P2093
Breukelmann D
Bànkfalvi A
Pschadka G
P2860
P304
P356
10.1046/J.1365-2559.1998.00472.X
P577
1998-08-01T00:00:00Z